Population
In vitro models infected with influenza B and polio type 2 viruses
Comparison
Benzimidazole, benzotriazole, and… vs Benzimidazole and untreated controls
Design
Preclinical
Authors
Loading...
No immediate clinical implications; leaves open whether HBB derivatives merit in vivo antiviral development.
HBB and its derivatives demonstrate selective antiviral activity against poliovirus type 2 in vitro without significant cellular toxicity.
Tamm et al. (1961) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: